Long‐Term Activation of Glucagon‐like peptide‐1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes

BACKGROUND: Mechanistic insights of glucagon‐like peptide‐1 receptor agonists remain incompletely identified, despite the efficacy in heart failure observed in clinical trials. Here, we evaluated the effects of dulaglutide on heart complications and illuminated its underlying mechanism. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Saiyang, Zhang, Min, Shi, Wenke, Xing, Yun, Huang, Yan, Fang, Wen‐xi, Liu, Shi‐qiang, Chen, Meng‐Ya, Zhang, Tong, Chen, Si, Zeng, Xiaofeng, Wang, Shasha, Deng, Wei, Tang, Qizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673690/
https://www.ncbi.nlm.nih.gov/pubmed/36172969
http://dx.doi.org/10.1161/JAHA.122.026728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673690/
https://www.ncbi.nlm.nih.gov/pubmed/36172969
http://dx.doi.org/10.1161/JAHA.122.026728

Ejemplares similares